Network Analysis to Risk Stratify Patients With Exercise Intolerance

Rationale: Current methods assessing clinical risk because of exercise intolerance in patients with cardiopulmonary disease rely on a small subset of traditional variables. Alternative strategies incorporating the spectrum of factors underlying prognosis in at-risk patients may be useful clinically, but are lacking. Objective: Use unbiased analyses to identify variables that correspond to clinical risk in patients with exercise intolerance. Methods and Results: Data from 738 consecutive patients referred for invasive cardiopulmonary exercise testing at a single center (2011–2015) were analyzed retrospectively (derivation cohort). A correlation network of invasive cardiopulmonary exercise testing parameters was assembled using |r|>0.5. From an exercise network of 39 variables (ie, nodes) and 98 correlations (ie, edges) corresponding to P<9.5e−46 for each correlation, we focused on a subnetwork containing peak volume of oxygen consumption (pVO2) and 9 linked nodes. K-mean clustering based on these 10 variables identified 4 novel patient clusters characterized by significant differences in 44 of 45 exercise measurements (P<0.01). Compared with a probabilistic model, including 23 independent predictors of pVO2 and pVO2 itself, the network model was less redundant and identified clusters that were more distinct. Cluster assignment from the network model was predictive of subsequent clinical events. For example, a 4.3-fold (P<0.0001; 95% CI, 2.2–8.1) and 2.8-fold (P=0.0018; 95% CI, 1.5–5.2) increase in hazard for age- and pVO2-adjusted all-cause 3-year hospitalization, respectively, were observed between the highest versus lowest risk clusters. Using these data, we developed the first risk-stratification calculator for patients with exercise intolerance. When applying the risk calculator to patients in 2 independent invasive cardiopulmonary exercise testing cohorts (Boston and Graz, Austria), we observed a clinical risk profile that paralleled the derivation cohort. Conclusions: Network analyses were used to identify novel exercise groups and develop a point-of-care risk calculator. These data expand the range of useful clinical variables beyond pVO2 that predict hospitalization in patients with exercise intolerance.

[1]  E. Gregg,et al.  Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force , 2015, Annals of Internal Medicine.

[2]  Henning Gall,et al.  Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension , 2016, BMC Pulmonary Medicine.

[3]  D. Kass,et al.  Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap , 2016, Circulation.

[4]  D. Mancini,et al.  Peak VO(2): a simple yet enduring standard. , 2000, Circulation.

[5]  B. Maron,et al.  The Invasive Cardiopulmonary Exercise Test , 2013, Circulation.

[6]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[7]  G. Lewis,et al.  Unexplained Exertional Dyspnea Caused by Low Ventricular Filling Pressures: Results from Clinical Invasive Cardiopulmonary Exercise Testing , 2016, Pulmonary circulation.

[8]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[9]  B. Maron,et al.  Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review. , 2016, JAMA cardiology.

[10]  M. Mäkelä,et al.  Tidal flow variability measured by impedance pneumography relates to childhood asthma risk , 2016, European Respiratory Journal.

[11]  N. Houstis,et al.  Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: The Role of Abnormal Peripheral Oxygen Extraction , 2015, Circulation. Heart failure.

[12]  A. Seely,et al.  Systems Biology and Clinical Practice in Respiratory Medicine. The Twain Shall Meet. , 2016, American journal of respiratory and critical care medicine.

[13]  V. Melenovský,et al.  Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. , 2016, European heart journal.

[14]  Peter Szolovits,et al.  Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension , 2017, Circulation research.

[15]  R. Arena,et al.  Exercise intolerance in pulmonary hypertension: mechanism, evaluation and clinical implications , 2016, Expert Review of Respiratory Medicine.

[16]  A. Opotowsky,et al.  Open label study of ambrisentan in patients with exercise pulmonary hypertension , 2017, Pulmonary circulation.

[17]  J. Granton,et al.  The pulmonary artery wedge pressure response to sustained exercise is time-variant in healthy adults , 2016, Heart.

[18]  B. Maron,et al.  Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy , 2017, Circulation. Heart failure.

[19]  Natalia C. Berry,et al.  Protocol for Exercise Hemodynamic Assessment: Performing an Invasive Cardiopulmonary Exercise Test in Clinical Practice , 2015, Pulmonary circulation.

[20]  M. Iannaccone,et al.  Tears are words that heart cannot express. , 2016, European heart journal.

[21]  A. Opotowsky,et al.  Age-related upper limits of normal for maximum upright exercise pulmonary haemodynamics , 2015, European Respiratory Journal.

[22]  R. Arena,et al.  Cardiopulmonary Exercise Testing in Heart Failure. , 2015, Current problems in cardiology.

[23]  S. Rosenkranz,et al.  Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum. , 2016, Journal of the American College of Cardiology.

[24]  A. Waxman,et al.  Exercise-Induced Pulmonary Arterial Hypertension , 2008, Circulation.

[25]  M. Humbert,et al.  Criteria for diagnosis of exercise pulmonary hypertension , 2015, European Respiratory Journal.

[26]  C. Ottenheijm,et al.  The striated muscles in pulmonary arterial hypertension: adaptations beyond the right ventricle , 2015, European Respiratory Journal.

[27]  S. Studenski,et al.  Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. , 2006, JAMA.

[28]  C. Stewart,et al.  A systems-based investigation into vitamin D and skeletal muscle repair, regeneration, and hypertrophy. , 2015, American journal of physiology. Endocrinology and metabolism.

[29]  Peter Szolovits,et al.  Genetic Misdiagnoses and the Potential for Health Disparities. , 2016, The New England journal of medicine.

[30]  H. Bogaard,et al.  Exercise pulmonary haemodynamics: a test in search of purpose , 2016, European Respiratory Journal.

[31]  R. Benza,et al.  The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. , 2012, Chest.

[32]  R. Arena Exercise testing and training in chronic lung disease and pulmonary arterial hypertension. , 2011, Progress in cardiovascular diseases.

[33]  H. Olschewski,et al.  Proposed new definition of exercise pulmonary hypertension decreases false-positive cases , 2016, European Respiratory Journal.

[34]  G. Grunwald,et al.  Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program , 2016, Circulation.

[35]  J. Eng,et al.  Determinants of improvement in walking capacity among individuals with chronic stroke following a multi-dimensional exercise program. , 2008, Journal of rehabilitation medicine.